Oncology & Cancer

Patients with advanced lymphoma in remission after T-cell therapy

Patients with non-Hodgkin lymphoma participating in an early-phase immunotherapy trial led by Fred Hutchinson Cancer Research Center had their advanced tumors disappear completely after their immune cells were genetically ...

Immunology

Study finds how to shutdown cancer's powerful master protein

The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex ...

page 6 from 40